Suggested Topics within your search.
Suggested Topics within your search.
- Pediatric Nursing 2
- Anesthesia 1
- Anesthesiology 1
- Blood 1
- Blood Cell Count 1
- Blood Cells 1
- Blood Cells-Physiology 1
- Cancer 1
- Critical Care Nursing 1
- Critical Illness 1
- Diagnosis, Differential 1
- Diseases 1
- Hematologic Diseases 1
- Hematologic Tests-methods 1
- Hematology 1
- Intraoperative Complications 1
- Medicine 1
- Oncology 1
- Patient Harm 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- Physical therapy 1
- adverse effects 1
- methods 1
- nursing 1
- prevention & control 1
-
121
The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review
Published 2024-01-01Get full text
Article -
122
-
123
Editorial: Obesity and cancer: the possible molecular links
Published 2025-02-01Get full text
Article -
124
Peripheral blood smear – An expeditious test in the preliminary diagnosis of bone marrow embolism in a case of multiple fractures: A case report
Published 2024-04-01“…A careful correlation of the clinical history of trauma, hematology auto-analyzer results, and the presence of bone marrow particles and fat globules in peripheral blood helped in arriving at the diagnosis of fat embolism in our case irrefutably.…”
Get full text
Article -
125
Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
Published 2025-03-01Get full text
Article -
126
-
127
Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
Published 2024-08-01“…The Russian Scientific Liver Society selected a panel of experts in the field of therapeutic and surgical hepatology, hematology, transfusion medicine to make reasoned statements and recommendations on the issue of treatment of thrombocytopenia before elective surgery / invasive procedures in patients with liver cirrhosis.Results. …”
Get full text
Article -
128
-
129
-
130
miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting
Published 2025-02-01“…To determine whether miR-182 promoter methylation is a predictive marker of clinical outcomes in AZA + VEN-treated AML patients in a real-world setting, we analyzed and compared the complete remission (CR)/CR with incomplete hematologic recovery (CRi) rate, overall survival (OS), and leukemia free-survival (LFS) across different methylation groups: miR-182 promoter hypomethylation (median value < 20.21%) and hypermethylation (> 20.21%) in a retrospective study. …”
Get full text
Article -
131
Global disparities in cancer supportive care: An international survey
Published 2024-09-01Get full text
Article -
132
-
133
-
134
A Nomogram Based on Circulating Inflammatory Factors for Predicting Prognosis of Newly Diagnosed Multiple Myeloma Patients
Published 2025-02-01“…Mowang Wang,1– 4,* Xiaoyan Yue,5,* Yingying Ding,5,* Zhen Cai,1,4 Haowen Xiao,5 He Huang,1– 4 Jingsong He1,4 1Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People’s Republic of China; 2Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, Zhejiang Province, People’s Republic of China; 3Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China; 4Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, Zhejiang Province, People’s Republic of China; 5Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: He Huang; Jingsong He, Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Zhejiang Province, 310006, People’s Republic of China, Email huanghe@zju.edu.cn; hejingsong@zju.edu.cnPurpose: The growth and survival of multiple myeloma (MM) cells depend heavily on bone marrow microenvironment, where inflammation emerges as a significant feature and is commonly associated with unfavorable prognosis in MM. …”
Get full text
Article -
135
-
136
-
137
Mitohormesis : la clé de voûte de la résistance thérapeutique des cellules cancéreuses
Published 2024-08-01Get full text
Article -
138
Preoperative evaluation of red blood cell distribution width as a promising biomarker for discriminating between benign and malignant breast tumors and assessing breast cancer acti...
Published 2024-04-01“…The RDW values were measured using an automated hematology analyzer. The study’s statistical analysis was conducted using SPSS software at a significance level of 0.05. …”
Get full text
Article -
139
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Published 2025-02-01Get full text
Article -
140
Challenges in diagnosis and treatment of cushing disease in a 12-year-old boy. Case report
Published 2025-02-01Get full text
Article